|
Real-time Estimate
Cboe BZX
16:18:55 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 17.62 USD | -1.18% |
|
-2.00% | +36.35% |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| 07-24 | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| Market Cap | 2.08B 1.79B 1.69B 1.54B 2.87B 196B 2.9B 19.98B 7.75B 100B 7.8B 7.63B 329B | P/E 2026 * |
-14.3x | P/E 2027 * | -21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.97B 1.7B 1.6B 1.46B 2.73B 186B 2.75B 18.96B 7.36B 95.18B 7.4B 7.24B 313B | EV / Sales 2026 * |
2.72x | EV / Sales 2027 * | 2.32x |
| Free-Float |
90.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NVCR | Delayed | |
CBOE
| NVCR | Real-time | |
|
Tradegate
| 038 | Real-time | |
|
Deutsche Boerse AG
| 038 | Delayed | |
|
Börse Stuttgart
| 038 | Delayed | |
|
Boerse Muenchen
| 038 | Real-time |
Last Transcript : NovoCure Limited
| 1 day | -1.07% | ||
| 1 week | -1.86% | ||
| Current month | +0.03% | ||
| 1 month | +15.24% | ||
| 3 months | +9.32% | ||
| 6 months | +32.74% | ||
| Current year | +36.54% |
| 1 week | 17.29 |  | 18.59 |
| 1 month | 15.23 | | 18.61 |
| Current year | 9.82 | | 21.45 |
| 1 year | 9.82 | | 21.45 |
| 3 years | 9.82 | | 34.13 |
| 5 years | 9.82 | | 143.69 |
| 10 years | 5.95 | | 232.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 46 | 30/11/2025 |
| Director of Finance/CFO | 52 | 31/12/2024 | |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | 16/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 59 | 31/12/2011 |
Bill Doyle
CHM | Chairman | 63 | 31/12/2008 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 04/08/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Chief Executive Officer | 1,905 | 0.0016% | ||
| 30/06/26 | Free | Head of Human Resources | 1,905 | 0.0016% | ||
| 30/06/26 | Free | General Counsel | 1,299 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -1.86% | +46.15% | -17.58% | 2.08B | |
| -0.31% | +0.28% | +19.35% | +22.82% | 12.71B | |
| -0.57% | -0.81% | +18.91% | +26.77% | 6.94B | |
| -0.32% | +21.37% | - | - | 6.67B | |
| +0.19% | -8.05% | +37.63% | +23.50% | 6.02B | |
| -1.80% | -1.13% | -19.84% | +45.46% | 5.08B | |
| -1.16% | -2.66% | -31.24% | -23.40% | 3.85B | |
| -1.18% | -1.34% | -0.34% | +132.41% | 1.75B | |
| -1.77% | -6.60% | +45.00% | -16.35% | 1.6B | |
| +8.55% | +2.99% | -0.67% | +20.06% | 1.3B | |
| Average | +0.08% | -0.38% | +12.77% | +23.74% | 4.8B | |
| Weighted average by Cap. | -0.39% | +1.14% | +13.29% | +23.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 726M 626M 590M 537M 1B 68.57B 1.01B 6.98B 2.71B 35.06B 2.73B 2.67B 115B | 805M 694M 654M 596M 1.11B 76.02B 1.12B 7.74B 3.01B 38.87B 3.02B 2.96B 128B |
| Net income | -142M -123M -115M -105M -197M -13.42B -198M -1.37B -530M -6.86B -533M -522M -22.53B | -84.78M -73.14M -68.9M -62.78M -117M -8.01B -118M -816M -317M -4.09B -318M -311M -13.45B |
| Net Debt | -105M -91M -85.72M -78.1M -146M -9.96B -147M -1.01B -394M -5.09B -396M -387M -16.73B | -210M -181M -171M -155M -291M -19.83B -293M -2.02B -784M -10.14B -788M -771M -33.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | US$17.65 | -1.01% | 128,726 |
| 02/09/26 | US$17.83 | +2.59% | 1,324,037 |
| 01/09/26 | US$17.38 | -1.53% | 800,360 |
| 31/08/26 | US$17.65 | -0.95% | 914,820 |
| 28/08/26 | US$17.82 | -0.94% | 855,579 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NVCR Stock
Select your edition
All financial news and data tailored to specific country editions
